Elanco Animal Health (ELAN) Interest Expenses (2018 - 2026)
Elanco Animal Health (ELAN) reported Interest Expenses of $57.0 million for Q1 2026, up 42.5% on a YoY basis from $40.0 million in Q1 2025, and down 28.75% sequentially from $80.0 million in Q4 2025.
Elanco Animal Health (ELAN) Interest Expenses (2018 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 9 years of Interest Expenses data on file, last reported at $57.0 million in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses rose 42.5% year-over-year to $57.0 million; the trailing twelve-month figure through Mar 2026 stood at $229.0 million (down 15.19% YoY), and the FY2025 full-year result was $220.0 million, down 25.68% from the prior year.
- Interest Expenses declined to $57.0 million in Q1 2026, from $80.0 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $169.0 million in Q4 2023 to a low of $40.0 million in Q1 2025.
- A 5-year average of $74.6 million and a median of $68.0 million in 2022 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses soared 172.58% in 2023 and slumped 39.39% in 2025, its largest moves.
- Tracing ELAN's Interest Expenses over 5 years: stood at $62.0 million in 2022, then soared by 172.58% to $169.0 million in 2023, then slumped by 36.69% to $107.0 million in 2024, then decreased by 25.23% to $80.0 million in 2025, then declined by 28.75% to $57.0 million in 2026.
- Business Quant data shows ELAN's Interest Expenses at $57.0 million in Q1 2026, $80.0 million in Q4 2025, and $52.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 1.77 Bn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 258.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.00 Mn |
| Mar 31, 2026 | 57.00 Mn |
| Dec 31, 2025 | 80.00 Mn |
| Dec 31, 2025 | 80.00 Mn |
| Sep 30, 2025 | 52.00 Mn |
| Sep 30, 2025 | 52.00 Mn |
| Jun 30, 2025 | 83.00 Mn |
| Jun 30, 2025 | 83.00 Mn |
| Mar 31, 2025 | 40.00 Mn |
| Mar 31, 2025 | 40.00 Mn |
| Dec 31, 2024 | 107.00 Mn |
| Dec 31, 2024 | 107.00 Mn |
| Sep 30, 2024 | 58.00 Mn |
| Sep 30, 2024 | 58.00 Mn |
| Jun 30, 2024 | 65.00 Mn |
| Jun 30, 2024 | 65.00 Mn |
| Mar 31, 2024 | 66.00 Mn |
| Mar 31, 2024 | 66.00 Mn |
| Dec 31, 2023 | 169.00 Mn |
| Dec 31, 2023 | 169.00 Mn |